Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases

Annals of Surgical Oncology

Volumn 17, Issue 2, 2010, Pages 492-501

  Chua, Terence C ^a   Saxena, Akshat ^a   Liauw, Winston ^a   Kokandi, Adel ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; DISEASE FREE SURVIVAL; HUMAN; LIVER METASTASIS; MEDLINE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77149163805     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0781-1     Document Type: Article

References (73)

1. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, based on November 2007 SEER data submission. 2008 [updated 2008; cited]. http://seer.cancer.gov/csr/1975-2005/.
2. W Scheithauer H Rosen GV Vornek C Sebesta D Depisch 1993 Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer BMJ. 306 752 755 10.1136/bmj.306.6880.752 1:STN:280:DyaK3s3lsl2isA%3D%3D 7683942
3. JY Douillard D Cunningham AD Roth M Navarro RD James P Karasek, et al. 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 9209 1041 1047 10.1016/S0140-6736(00)02034-1 1:CAS:528:DC%2BD3cXisFOnsb4%3D 10744089
4. RM Goldberg DJ Sargent RF Morton CS Fuchs RK Ramanathan SK Williamson, et al. 2004 A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 1 23 30 10.1200/JCO.2004.09.046 1:CAS:528:DC%2BD2cXpsVKitbY%3D 14665611 (Pubitemid 41095110)
5. T Andre C Boni L Mounedji-Boudiaf M Navarro J Tabernero T Hickish, et al. 2004 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer New Engl J Med 350 23 2343 2351 10.1056/NEJMoa032709 1:CAS:528: DC%2BD2cXks1Gjt78%3D 15175436 (Pubitemid 38702845)
6. C Bokemeyer I Bondarenko A Makhson JT Hartmann J Aparicio F de Braud, et al. 2009 Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol 27 5 663 671 10.1200/JCO.2008.20.8397 1:CAS:528:DC%2BD1MXjsVCjsrk%3D 19114683
7. H Hurwitz L Fehrenbacher W Novotny T Cartwright J Hainsworth W Heim, et al. 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [see comment] N Engl J Med 350 23 2335 2342 10.1056/NEJMoa032691 1:CAS:528:DC%2BD2cXks1Gjt74%3D 15175435 (Pubitemid 38702844)
8. LB Saltz S Clarke E Diaz-Rubio W Scheithauer A Figer R Wong, et al. 2008 Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study J Clin Oncol 26 12 2013 2019 10.1200/JCO.2007.14.9930 1:CAS:528:DC%2BD1cXlvFaqs7g%3D 18421054
9. E Van Cutsem I Lang G D'haens V Moiseyenko J Zaluski G Folprecht, et al. 2008 KRAS status and efficacy in the firstline treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: the CRYSTAL experience J Clin Oncol 26 Suppl 5s
10. S Bengmark L Hafstrom 1969 The natural history of primary and secondary malignant tumours of the liver Cancer. 23 198 202 10.1002/1097-0142(196901)23: 1<198::AID-CNCR2820230126>3.0.CO;2-J 1:STN:280:DyaF1M%2FptFWmuw%3D%3D 5763253
11. Y Fong N Kemeny P Paty LH Blumgart AM Cohen 1996 Treatment of colorectal cancer: Hepatic metastasis Semin Surg Oncol. 12 219 252 10.1002/(SICI)1098- 2388(199607/08)12:4<219::AID-SSU3>3.0.CO;2-8 1:STN:280: DyaK28vislShtw%3D%3D 8829283 (Pubitemid 26255863)
12. N Kemeny F Fata 1999 Arterial, portal or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma J Hepatobiliary Pancreatic Surg. 6 39 49 10.1007/s005340050082 1:STN:280:DyaK1MzmslOksg%3D%3D
13. Steele GJ, Ravikumar TS. Resection of hepatic metastases from colorectal metastases: biologic perspectives. Ann Surg. 1989;210(127-138).
14. G McMahon 2000 VEGF receptor signaling in tumor angiogenesis Oncologist. 5 s3 s10 10.1634/theoncologist.5-suppl-1-3
15. AC Chiang J Massague 2008 Molecular Basis of Metastasis N Engl J Med 359 26 2814 2823 10.1056/NEJMra0805239 1:CAS:528:DC%2BD1cXhsFCnt7bF 19109576 2008 December 25
16. Y Fong AM Cohen JG Fortner WE Enker AD Turnbull DG Coit, et al. 1997 Liver resection for colorectal metastases J Clin Oncol 15 3 938 946 1:STN:280:DyaK2s3htlynsA%3D%3D 9060531
17. VP Khatri NJ Petrelli J Belghiti 2005 Extending the Frontiers of Surgical Therapy for Hepatic Colorectal Metastases: Is There a Limit? J Clin Oncol 23 33 8490 8499 10.1200/JCO.2004.00.6155 16230676 (Pubitemid 46260246)
18. JS Tomlinson WR Jarnagin RP DeMatteo Y Fong P Kornprat M Gonen, et al. 2007 Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure J Clin Oncol 25 29 4575 4580 10.1200/JCO.2007.11.0833 17925551 2007 Oct 10 (Pubitemid 350035315)
19. L Vigano A Ferrero RL Tesoriere L Capussotti 2008 Liver surgery for colorectal metastases: results after 10 years of follow-up. long-term survivors, late recurrences, and prognostic role of morbidity Ann Surg Oncol 15 9 2458 2464 10.1245/s10434-008-9935-9 18463927 2008 Sep 1
20. TM Pawlik 2008 Expanding criteria for resectability of colorectal liver metastases Oncologist 13 1 51 64 10.1634/theoncologist.2007-0142 18245012 (Pubitemid 351206696)
21. G Garcea SL Ong GJ Maddern 2008 Inoperable colorectal liver metastases: a declining entity? Eur J Cancer 44 17 2555 2572 10.1016/j.ejca.2008.07.028 1:STN:280:DC%2BD1cjisVOktA%3D%3D 18755585
22. GD Leonard B Brenner NE Kemeny 2005 Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal Carcinoma J Clin Oncol 23 9 2038 2048 10.1200/JCO.2005.00.349 1:CAS:528:DC%2BD2MXjt1Cku7Y%3D 15774795 2005 Ma 20 (Pubitemid 46211384)
23. H Nakano E Oussoultzoglou E Rosso S Casnedi M-P Chenard-Neu P Dufour, et al. 2008 Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 1 118 124 10.1097/SLA.0b013e31815774de 18156931
24. J-N Vauthey TM Pawlik D Ribero T-T Wu D Zorzi PM Hoff, et al. 2006 Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 13 2065 2072 10.1200/JCO.2005.05.3074 1:CAS:528:DC%2BD28Xlt1amurY%3D 16648507 May 1 (Pubitemid 46622116)
25. A Zaniboni V Torri A Tinazzi C Codignola R Faggiuolo E Sperti 2005 Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey Tumori 91 5 383 387 1:CAS:528:DC%2BD2MXhtlWrurfP 16459633 Sep-Oct
26. FKS Welsh HS Tilney PP Tekkis TG John M Rees 2007 Safe liver resection following chemotherapy for colorectal metastases is a matter of timing Br J Cancer 96 7 1037 1042 10.1038/sj.bjc.6603670 1:STN:280:DC%2BD2s3gt12jtA%3D%3D 17353923 Apr 10 (Pubitemid 46608314)
27. A Wein C Riedel W Bruckl S Merkel R Ott B Hanke, et al. 2003 Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer Oncology 64 2 131 138 10.1159/000067772 1:CAS:528: DC%2BD3sXntFShsg%3D%3D 12566910 (Pubitemid 36173378)
28. D Tamandl B Gruenberger B Herberger S Schoppmann M Bodingbauer M Schindl, et al. 2007 Selective resection of colorectal liver metastases Eur J Surg Oncol 33 2 174 182 10.1016/j.ejso.2006.09.008 1:STN:280:DC%2BD2s7ksFamtw%3D%3D 17046194 (Pubitemid 46336547)
29. E Sperti R Faggiuolo A Gerbino A Magnino A Muratore C Ortega, et al. 2006 Outcome of Metastatic Colorectal Cancer: Analysis of a Consecutive Series of 229 Patients. The Impact of a Multidisciplinary Approach Dis Colon Rectum 49 10 1596 1601 10.1007/s10350-006-0662-7 16988853 (Pubitemid 44796132)
30. RM Small N Lubezky E Shmueli A Figer D Aderka R Nakache, et al. 2009 Response to Chemotherapy Predicts Survival Following Resection of Heaptic Colorectal Metastases in Patients Treated With Neoadjuvant Therapy J Surg Oncol. 99 93 98 10.1002/jso.21207 19065637
31. B Nordlinger H Sorbye B Glimelius GJ Poston PM Schlag P Rougier, et al. 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.[see comment] Lancet 371 9617 1007 1016 10.1016/S0140-6736(08)60455-9 1:CAS:528:DC%2BD1cXjs1Sltbg%3D 18358928 Mar 22
32. N Lubezky R Geva E Shmueli R Nakache JM Klausner A Figer, et al. 2009 Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? World J Surg. 33 1028 1034 10.1007/s00268-009-9945-1 19234865
33. B Gruenberger D Tamandl J Schueller W Scheithauer C Zielinski F Herbst, et al. 2008 Bevacizumab, Capecitabine and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer J Clin Oncol 26 11 1830 1835 10.1200/JCO.2007.13.7679 1:CAS:528:DC%2BD1cXmsFemsbg%3D 18398148
34. B Gruenberger W Scheithauer R Punzengruber C Zielinski D Tamandl T Gruenberger 2008 Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer. 8 120 10.1186/1471-2407-8-120 18439246 (Pubitemid 351715876)
35. Gallagher DJ, Zheng J, Capanu M, Haviland D, Paty P, Dematteo RP, et al. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases. Ann Surg Oncol. 2009;16(7):1844-51.
36. DG Blazer III Y Kishi DM Maru S Kopetz YS Chun MJ Overman, et al. 2008 Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 33 5344 5351 10.1200/JCO.2008.17.5299 18936472 Nov 20
37. OF Bathe S Ernst FR Sutherland E Dixon C Butts D Bigam, et al. 2009 A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases BMC Cancer 20 9 156 10.1186/1471-2407-9-156 [Epub ahead of print]
38. MM Aloysius AM Zaitoun IJ Beckingham KR Neal GP Aithal EM Bessell, et al. 2007 The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study Virchows Arch. 451 943 948 10.1007/s00428-007-0497-1 1:CAS:528:DC%2BD2sXht1KkurrL 17805566 (Pubitemid 350060742)
39. R Adam DA Wicherts RJ de Haas T Aloia F Levi B Paule, et al. 2008 Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26 10 1635 1641 10.1200/JCO.2007.13.7471 18375892
40. R Adam G Pascal D Castaing D Azoulay V Delvart B Paule, et al. 2004 Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240 6 1052 1061 10.1097/01.sla. 0000145964.08365.01 15570210 discussion 61-4 (Pubitemid 39602132)
41. CR Scoggins ML Campbell CS Landry BA Slomiany CE Woodall KM McMasters, et al. 2009 Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases Ann Surg Oncol 16 1 35 41 10.1245/s10434-008-0190-x 18987915
42. Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Dibero D, et al. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. Ann Surg Oncol. 2009;16(7):1809-19.
43. HZ Malik S Farid A Al-Mukthar A Anthoney GJ Toogood JPA Lodge, et al. 2007 A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study Ann Surg Oncol 14 12 3519 3526 10.1245/s10434-007-9533-2 1:STN:280:DC%2BD2snnsFKjtg%3D%3D 17912590 (Pubitemid 350160110)
44. JC Hewes S Dighe RW Morris RR Hutchins S Bhattacharya BR Davidson 2007 Preoperative chemotherapy and the outcome of liver resection for colorectal metastases World J Surg 31 2 353 364 10.1007/s00268-006-0103-8 1:STN:280:DC%2BD2s3hsVCmsw%3D%3D 17219289 discussion 65-6 (Pubitemid 46183523)
45. YS Chun J-N Vauthey D Ribero M Donadon JT Mullen C Eng, et al. 2007 Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival J Gastrointest Surg 11 11 1498 1504 10.1007/s11605-007-0272-2 17849166 discussion 504-5
46. PJ Allen N Kemeny W Jarnagin R DeMatteo L Blumgart Y Fong 2003 Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases J Gastrointest Surg 7 1 109 115 10.1016/S1091-255X(02)00121-X 12559192 discussion 16-7 (Pubitemid 36875808)
47. K Tanaka R Adam H Shimada D Azoulay F Levi H Bismuth 2003 Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver.[see comment] Br J Surg 90 8 963 969 10.1002/bjs.4160 1:STN:280:DC%2BD3szntVSltA%3D%3D 12905549 (Pubitemid 37026325)
48. TD Yan D Black R Savady PH Sugarbaker 2006 Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol 24 24 4011 4019 10.1200/JCO.2006.07.1142 16921055 Aug 20 (Pubitemid 46630752)
49. J Pfannschmidt H Dienemann H Hoffmann 2007 Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series Ann Thoracic Surg 84 1 324 338 10.1016/j.athoracsur.2007.02.093 (Pubitemid 46921128)
50. PC Simmonds JN Primrose JL Colquitt OJ Garden GJ Poston M Rees 2006 Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies Br J Cancer 94 7 982 999 10.1038/sj.bjc.6603033 1:STN:280:DC%2BD287pt1altw%3D%3D 16538219 Apr 10
51. G Folprecht A Grothey S Alberts HR Raab CH Kohne 2005 Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann Oncol 16 8 1311 1319 10.1093/annonc/mdi246 1:STN:280:DC%2BD2MzotFamsA%3D%3D 15870084 2005 August 1 (Pubitemid 41158476)
52. R Adam E Avisar A Ariche S Giachetti D Azoulay D Castaing, et al. 2001 Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases Ann Surg Oncol 8 4 347 353 10.1007/s10434-001-0347-3 1:STN:280:DC%2BD3M3lsVWntg%3D%3D 11352309 2001 April 1
53. British Journal of Surgery. Benoist S, Brouquet A, Penna C, Julie C, El Hajjam M, Chagnon S, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006;24(24):3939-45.
54. M Rees PP Tekkis FK Welsh T O'Rouke TG John 2008 Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 1 125 135 10.1097/SLA. 0b013e31815aa2c2 18156932
55. TM Pawlik CR Scoggins D Zorzi EK Abdalla A Andres C Eng, et al. 2005 Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases Ann Surg 241 5 715 724 10.1097/01.sla.0000160703.75808.7d 15849507 (Pubitemid 40604917)
56. R Niu TD Yan JC Zhu D Black F Chu DL Morris 2007 Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma Ann Surg Oncol 14 7 2078 2087 10.1245/s10434-007-9400-1 17473951 (Pubitemid 46988268)
57. HZ Malik KR Prasad KJ Halazun A Aldoori A Al-Mukhtar D Gomez, et al. 2007 Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases Ann Surg 246 5 806 814 10.1097/SLA. 0b013e318142d964 17968173 (Pubitemid 350035657)
58. RJ de Haas DA Wicherts E Flores D Azoulay D Castaing R Adam 2008 R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248 4 626 637 18936576
59. S Connor MG Hart DN Redhead H Ireland KK Madhavan RW Parks, et al. 2007 Follow-up and outcomes for resection of colorectal liver metastases in Edinburgh Eur J Surg Oncol 33 1 55 60 1:STN:280:DC%2BD2s%2Flt1aqsA%3D%3D 17095181
60. MA Choti JV Sitzmann MF Tiburi W Sumetchotimetha R Rangsin RD Schulick, et al. 2002 Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases Ann Surg 235 6 759 766 10.1097/00000658-200206000-00002 12035031 (Pubitemid 34547293)
61. D Elias A Cavalcanti JC Sabourin JP Pignon M Ducreux P Lasser 1998 Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases J Surg Oncol 69 2 88 93 10.1002/(SICI)1096- 9098(199810)69:2<88::AID-JSO8>3.0.CO;2-X 1:STN:280:DyaK1M%2FitlKqtQ%3D%3D 9808511 (Pubitemid 28515966)
62. M Karoui C Penna M Amin-Hashem E Mitry S Benoist B Franc, et al. 2006 Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 1 1 7 10.1097/01.sla.0000193603.26265. c3 16371728 (Pubitemid 43054046)
63. B Angliviel S Benoist C Penna M El Hajjam S Chagnon C Julié, et al. 2009 Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases Ann Surg Oncol 16 5 1247 1253 10.1245/s10434-009-0385-9 19252951
64. JD White PW Hewett D Kosuge T McCulloch BC Enholm J Carmichael, et al. 2002 Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma Cancer Res 62 6 1669 1675 1:CAS:528:DC%2BD38XisVSisLc%3D 11912138 2002 March 1
65. G Lindmark B Gerdin C Sundberg L Pahlman R Bergstrom B Glimelius 1996 Prognostic significance of the microvascular count in colorectal cancer J Clin Oncol 14 2 461 466 1:STN:280:DyaK283itlCjsA%3D%3D 8636758 1996 February 1 (Pubitemid 26051008)
66. S Ogino K Nosho GJ Kirkner K Shima N Irahara S Kure, et al. 2009 PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer J Clin Oncol 27 9 1477 1484 10.1200/JCO.2008.18.6544 1:CAS:528:DC%2BD1MXksF2hsL4%3D 19237633 2009 March 20
67. XF Sun JM Carstensen O Stal S Wingren T Hatschek B Nordenskjold, et al. 1992 Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma Lancet 340 8832 1369 1373 10.1016/0140-6736(92)92558-W 1:STN:280:DyaK3s%2FnvVGhtg%3D%3D 1360088
68. E Dotor M Cuatrecases M Martinez-Iniesta M Navarro F Vilardell E Guino, et al. 2006 Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment J Clin Oncol 24 10 1603 1611 10.1200/JCO.2005.03.5253 1:CAS:528: DC%2BD28XjvFykt7Y%3D 16575011 2006 April 1 (Pubitemid 46638784)
69. T Watanabe T-T Wu PJ Catalano T Ueki R Satriano DG Haller, et al. 2001 Molecular predictors of survival after adjuvant chemotherapy for colon cancer N Engl J Med 344 16 1196 1206 10.1056/NEJM200104193441603 1:CAS:528: DC%2BD3MXjsV2ms74%3D 11309634 2001 April 19 (Pubitemid 32319494)
70. CP Neal G Garcea H Doucas MM Manson CD Sutton AR Dennison, et al. 2006 Molecular prognostic markers in resectable colorectal liver metastases: A systematic review Eur J Cancer 42 12 1728 1743 10.1016/j.ejca.2006.01.056 1:CAS:528:DC%2BD28XotFyltL0%3D 16815701 (Pubitemid 44149078)
71. MW Kattan M Gonen WR Jarnagin R DeMatteo M D'Angelica M Weiser, et al. 2008 A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer Ann Surg 247 2 282 287 10.1097/SLA. 0b013e31815ed67b 18216534 (Pubitemid 351156771)
72. NJ Petrelli 2008 Perioperative or adjuvant therapy for resectable colorectal hepatic metastases J Clin Oncol 26 30 4862 4863 10.1200/JCO.2008.18. 5868 18794535 2008 October 20
73. M Buyse T Burzykowski K Carroll S Michiels DJ Sargent LL Miller, et al. 2007 Progression-free survival is a surrogate for survival in advanced colorectal cancer J Clin Oncol 25 33 5218 5224 10.1200/JCO.2007.11.8836 1:CAS:528:DC%2BD2sXhsVKnsbzP 18024867 2007 November 20 (Pubitemid 350232253)